BioEnterprise is pleased to announce the winners of the Third Annual
Medical Capital Innovation Competition (MCIC), awarded yesterday at the
Global Center for Health Innovation. These winning companies were chosen
from a field of 21 U.S. and Canadian competitors creating augmented and
virtual reality healthcare technologies.
The winners in the professional division are:
First Place ($50,000): Vivid
Vision (San Francisco, Calif.): Founded by a programmer
looking for a new kind of treatment for his amblyopia (lazy eye), Vivid
Vision uses virtual reality to train amblyopia sufferers’ weaker eye to
improve binocular vision. The company was represented at MCIC by its
director of optometry, Brian Dornbos, who described the technology as
bringing innovation to a treatment that hasn’t changed for many years,
usually requiring use of an eye patch. Dornbos said that Vivid Vision’s
technology is now available in 280 vision clinics across four continents.
Second Place ($25,000): MediView
XR (Toledo, Ohio): Founder John Black is a physiologist
who has worked extensively in medical device design and sales, and has
developed what the company calls Real-Time, Fused-Holographic
Visualization (RTFHV). The technology will allow a healthcare provider
to see inside a patient using a 3D hologram instead of a conventional 2D
display screen. The company’s initial focus is on cancer care. MCIC
judge Neda Amidi of Plug and Play also chose to match MediView XR’s
prize with an additional $25,000.
Third Place ($15,000): Augment
Therapy (Chagrin Falls, Ohio): Augment Therapy was
founded by Lindsay Watson, a physical therapist who specializes in
pediatrics. Her technology uses augmented reality to improve kids’
adherence to physical therapy through interactive play-based exercises,
while also collecting data that physicians and physical therapists can
use to measure kids’ progress toward healing.
The winners in the collegiate division are:
First Place ($6,000): Virtual Reality Pediatric Mock MRI (University
of Southern California): This virtual exposure therapy tool prepares
children for an MRI, using a virtual reality headset to recreate the MRI
experience.
Second Place ($3,000): SurgeonMR (Johns Hopkins University):
SurgeonMR is creating a mixed-reality technology to help in training and
practice of surgical techniques.
In addition to cash prizes, selected teams were extended collaboration
offers from healthcare institutions. The first-place winners in both
divisions will also have the opportunity to exhibit their technologies
at the HIMSS20 Conference in March 2020.
The 21 finalists were chosen from a field of 79 applicant teams from 19
states and 16 countries. For a full list of finalists and judges, visit mcic.bioenterprise.com.
BioEnterprise receives support for the Medical Capital Innovation
Competition from Cuyahoga County, JumpStart, HIMSS (Healthcare
Information and Management Systems Society) and the Global Center for
Health Innovation. Healthcare partners include Cleveland Clinic
Innovations, University Hospitals, The MetroHealth System and ProMedica.
Supporting sponsors include Case Western Reserve University and Develoco.
ABOUT BIOENTERPRISE
BioEnterprise is a business formation, recruitment, and acceleration
effort designed to grow the Northeast Ohio healthcare industry. Located
in Cleveland, at the Global Center for Health Innovation and in
University Circle, BioEnterprise provides management counsel and support
services to health IT, medical device, and biopharmaceutical companies.
In addition, BioEnterprise convenes and leads strategy for
industry-building initiatives such as the Medical Capital Innovation
Competition, HIT in the CLE and the Global Center for Health Innovation.
BioEnterprise partners are Case Western Reserve University, Cleveland
Clinic, The MetroHealth System and University Hospitals. Additional
technology partners include the NASA Glenn Research Center, Cleveland
State University and BioOhio. Since 2002, BioEnterprise and its partners
have created, recruited and accelerated more than 350 health IT, medical
device, and biopharmaceutical companies, and have helped these companies
raise more than $3 billion in new funding. To learn more: www.BioEnterprise.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190419005139/en/